iCo Therapeutics (iCo Therapeutics) Tax Rate % : 0.00% (As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. iCo Therapeutics's Tax Expense for the three months ended in Mar. 2021 was $0.00 Mil. iCo Therapeutics's Pre-Tax Income for the three months ended in Mar. 2021 was $-0.61 Mil. Therefore, iCo Therapeutics's Tax Rate % for the quarter that ended in Mar. 2021 was 0.00%.

iCo Therapeutics Tax Rate % Historical Data

The historical data trend for iCo Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Tax Rate % Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Tax Rate %

Get a 7-Day Free Trial

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

iCo Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

iCo Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2020 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2020 )	/	Pre-Tax Income (A: Dec. 2020 )
	=	0	/	-1.162
	=	0.00 %

iCo Therapeutics's Tax Rate % for the quarter that ended in Mar. 2021 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2021 )	/	Pre-Tax Income (Q: Mar. 2021 )
	=	0	/	-0.614
	=	0.00 %

iCo Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines